ArticleFrontiers in nutrition2025
Therapeutic effects of olive leaf tea (
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Olive leaf has strong antibacterial and anti-inflammatory properties, potentially modulating gut microbiota composition. This may help address small intestinal bacterial overgrowth (SIBO), a gastrointestinal (GI) problem causing malabsorption and potential complications. Objective: This study aimed to observe the effect of olive leaf tea (OLT) on GI symptoms, body composition, and the hydrogen/methane breath test among patients suffering from SIBO. Methods: A total of 49 SIBO individuals, confirmed after a glucose breath test (GBT), were divided randomly into two groups. The treatment group ( Results: In the intervention group, there was a significant decrease observed in GSRS score (from 19 to 6.8), symptomatic score (4.1 to 1.7), H Conclusion: This study concludes that OLT consumption might have therapeutic benefits against SIBO by alleviating symptoms and normalizing GBT, but does not significantly improve body composition parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.